Quest Diagnostics Incorporated (DGX) is in Healthcare, Diagnostics & Research, based in United States, listed on NYSE. Market cap 25.48B USD. 52-week range 171.18 to 248.84 USD. Trailing P/E 24.5. Data as of 2026-10-09.
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, ...